Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 598052, 8 pages
http://dx.doi.org/10.1155/2014/598052
Research Article

Early Treatment Response Monitoring Using 2-Deoxy-2-[18F]fluoro-D-glucose Positron Emission Tomography Imaging during Fractionated Radiotherapy of Head Neck Cancer Xenografts

1Department of Radiation Oncology, William Beaumont Hospital, 3811 West Thirteen Mile Road, 105-RI, Royal Oak, MI 48073, USA
2Department of Pathology, William Beaumont Hospital, Royal Oak, MI 48073, USA
3Department of Nuclear Medicine, William Beaumont Hospital, Royal Oak, MI 48073, USA

Received 22 November 2013; Accepted 28 March 2014; Published 28 April 2014

Academic Editor: Xin-yuan Guan

Copyright © 2014 Jiayi Huang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Ferlay, H.-R. Shin, F. Bray, D. Forman, C. Mathers, and D. M. Parkin, “Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008,” International Journal of Cancer, vol. 127, no. 12, pp. 2893–2917, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. R. Corvò, “Evidence-based radiation oncology in head and neck squamous cell carcinoma,” Radiotherapy and Oncology, vol. 85, no. 1, pp. 156–170, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. N. Lee, J. Mechalakos, D. R. Puri, and M. Hunt, “Choosing an intensity-modulated radiation therapy technique in the treatment of head-and-neck cancer,” International Journal of Radiation Oncology*Biology*Physics, vol. 68, no. 5, pp. 1299–1309, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. J. A. Bonner, P. M. Harari, J. Giralt et al., “Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival,” The Lancet Oncology, vol. 11, no. 1, pp. 21–28, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. M. E. Juweid and B. D. Cheson, “Positron-emission tomography and assessment of cancer therapy,” The New England Journal of Medicine, vol. 354, no. 5, pp. 496–507, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. H. Hautzel and H.-W. Müller-Gärtner, “Early changes in fluorine-18-FDG uptake during radiotherapy,” The Journal of Nuclear Medicine, vol. 38, no. 9, pp. 1384–1386, 1997. View at Google Scholar · View at Scopus
  7. G. J. Hunter, L. M. Hamberg, N. Choi, R. K. Jain, T. McCloud, and A. J. Fischman, “Dynamic T1-weighted magnetic resonance imaging and positron emission tomography in patients with lung cancer: correlating vascular physiology with glucose metabolism,” Clinical Cancer Research, vol. 4, no. 4, pp. 949–955, 1998. View at Google Scholar · View at Scopus
  8. E. Brun, E. Kjellén, J. Tennvall et al., “FDG pet studies during treatment: prediction of therapy outcome in head and neck squamous cell carcinoma,” Head and Neck, vol. 24, no. 2, pp. 127–135, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. P. Castaldi, V. Rufini, F. Bussu et al., “Can “early” and “late”18F-FDG PET-CT be used as prognostic factors for the clinical outcome of patients with locally advanced head and neck cancer treated with radio-chemotherapy?” Radiotherapy and Oncology, vol. 103, no. 1, pp. 63–68, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. G. Ceulemans, M. Voordeckers, A. Farrag, D. Verdries, G. Storme, and H. Everaert, “Can 18-FDG-PET during radiotherapy replace post-therapy scanning for detection/demonstration of tumor response in head-and-neck cancer?” International Journal of Radiation Oncology*Biology*Physics, vol. 81, no. 4, pp. 938–942, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Hentschel, S. Appold, A. Schreiber et al., “Early FDG PET at 10 or 20 Gy under chemoradiotherapy is prognostic for locoregional control and overall survival in patients with head and neck cancer,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 38, no. 7, pp. 1203–1211, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Huang, J. L. Chunta, M. Amin et al., “Detailed characterization of the early response of head-neck cancer xenografts to irradiation using 18F-FDG-PET imaging,” International Journal of Radiation Oncology*Biology*Physics, vol. 84, no. 2, pp. 485–491, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Yaromina, M. Krause, H. Thames et al., “Pre-treatment number of clonogenic cells and their radiosensitivity are major determinants of local tumour control after fractionated irradiation,” Radiotherapy and Oncology, vol. 83, no. 3, pp. 304–310, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. K. Higashi, A. C. Clavo, and R. L. Wahl, “In vitro assessment of 2-fluoro-2-deoxy-D-glucose, L-methionine and thymidine as agents to monitor the early response of a human adenocarcinoma cell line to radiotherapy,” The Journal of Nuclear Medicine, vol. 34, no. 5, pp. 773–779, 1993. View at Google Scholar · View at Scopus
  15. B. M. Burt, J. L. Humm, D. A. Kooby et al., “Using positron emission tomography with [18F]FDG to predict tumor behavior in experimental colorectal cancer,” Neoplasia, vol. 3, no. 3, pp. 189–195, 2001. View at Publisher · View at Google Scholar · View at Scopus
  16. T. Higashi, T. Saga, Y. Nakamoto et al., “Relationship between retention index in dual-phase 18F-FDG PET, and hexokinase-II and glucose transporter-1 expression in pancreatic cancer,” The Journal of Nuclear Medicine, vol. 43, no. 2, pp. 173–180, 2002. View at Google Scholar · View at Scopus
  17. C.-Y. O. Wong, D. Noujaim, H. F. Fu et al., “Time sensitivity: a parameter reflecting tumor metabolic kinetics by variable dual-time f-18 FDG PET imaging,” Molecular Imaging and Biology, vol. 11, no. 4, pp. 283–290, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. C. J. Hoekstra, O. S. Hoekstra, and A. A. Lammertsma, “On the use of image-derived input functions in oncological fluorine-18 fluorodeoxyglucose positron emission tomography studies,” European Journal of Nuclear Medicine, vol. 26, no. 11, pp. 1489–1492, 1999. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Carmichael, W. G. Degraff, J. Gamson et al., “Radiation sensitivity of human lung cancer cell lines,” European Journal of Cancer and Clinical Oncology, vol. 25, no. 3, pp. 527–534, 1989. View at Google Scholar · View at Scopus
  20. T. Björk-Eriksson, C. West, E. Karlsson, and C. Mercke, “Tumor radiosensitivity (SF2) is a prognostic factor for local control in head and neck cancers,” International Journal of Radiation Oncology*Biology*Physics, vol. 46, no. 1, pp. 13–19, 2000. View at Publisher · View at Google Scholar · View at Scopus
  21. B. Stausbøl-Grøn and J. Overgaard, “Relationship between tumour cell in vitro radiosensitivity and clinical outcome after curative radiotherapy for squamous cell carcinoma of the head and neck,” Radiotherapy and Oncology, vol. 50, no. 1, pp. 47–55, 1999. View at Publisher · View at Google Scholar · View at Scopus
  22. N. Charles and E. C. Holland, “The perivascular niche microenvironment in brain tumor progression,” Cell Cycle, vol. 9, no. 15, pp. 3012–3021, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. E. E. Graves, A. Maity, and Q.-T. Le, “The tumor microenvironment in non-small-cell lung cancer,” Seminars in Radiation Oncology, vol. 20, no. 3, pp. 156–163, 2010. View at Publisher · View at Google Scholar · View at Scopus